1. 20 Jul 2012  |  North America  |  Market Research

    Vital Signs - Healthcare News - The Analyst's Perspective - July Issue

     

    This issue of Vital Signs, released on July 20, 2012, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences, Advanced Medical Technology and Connected Health.

    $1,500.00
  2. 13 Jul 2012  |  North America  |  Market Research

    Vital Signs - Getting Down to the Business of Green Medical Imaging

     

    This issue of Vital Signs, released on July 13, 2012, provides an insight in to the green medical imaging market. Additionally, a company spotlight is provided for Karos Health. Building on 20 years of experience in the diagnostic imaging industry, Karos Health has a particular focus on creating secure and seamless imaging exchange networks. K...

    $1,500.00
  3. 27 Jun 2012  |  North America  |  Market Research

    Vital Signs - Healthcare News - The Analyst's Perspective - June Issue

     

    This issue of Vital Signs, released on June 27, 2012, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences, Advanced Medical Technology and Connected Health.

    $1,500.00
  4. This issue of Vital Signs, released on June 26, 2012, provides commentary on the Digital Health Summer Summit by Healthcare Research Director, Daniel Ruppar. This event took place on June 14-15 2012 in San Diego, California. Frost & Sullivan was a Strategic Partner with the event; participation included speaking engagement by Senior Industry Analy...

    $1,500.00
  5. This issue of Vital Signs, released on June 20, 2012, provides an insight in to the global biosimilars market. Additionally, a company spotlight is provided for Dragonfly Sciences. Dragonfly Sciences is a private biotechnology company specializing in the development of biosimilar monoclonal antibodies and soluble receptors. Reimbursement and r...

    $1,500.00
  6. 21 May 2012  |  North America  |  Market Research

    Vital Signs - Healthcare News - The Analyst's Perspective - May Issue

     

    This issue of Vital Signs, released on May 21, 2012, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences, Advanced Medical Technology and Connected Health.

    $1,500.00
  7. 07 May 2012  |  North America  |  Market Research

    Vital Signs - Cutting the Fat: Taking a Look at Wasteful Healthcare Spending

     

    This issue of Vital Signs, released on May 7, 2012, provides an insight in to healthcare spending in the U.S. Additionally, a company spotlight is provided for Apollo Endosurgery, Inc.Apollo Endosurgery is a privately held company based out of Austin, Texas. It is focused on the development of novel minimally and less-invasive surgical tools. R...

    $1,500.00
  8. 02 May 2012  |  North America  |  Market Research

    Vital Signs - Medical Image Sharing and Management Drives Collaborative Care

     

    This issue of Vital Signs, released on May 2, 2012, provides a strategic insight on use of IT solutions for medical image sharing and management. Additionally, a company spotlight is provided for Laurel Bridge Software. Engineers from Laurel Bridge Software, Inc. and Blair Computing Systems, Inc. have been developing technical software since 19...

    $1,500.00
  9. 23 Apr 2012  |  North America  |  Market Research

    Vital Signs - Healthcare News - The Analyst's Perspective - April Issue

     

    This issue of Vital Signs, released on April 23, 2012, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences, Advanced Medical Technology and Connected Health.

    $1,500.00
  10. This issue of Vital Signs, released on March 30, 2012, provides a strategic insight on the next-generation sequencing services market. Additionally, a company spotlight is provided for Foundation Medicine. Founded in 2010, the cancer diagnostics firm aims to transform cancer care by including comprehensive molecular analysis of tumors from next-...

    $1,500.00